These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8019683)

  • 21. Differential sprouting responses in axonal fiber systems in the dentate gyrus following lesions of the perforant path in WLDs mutant mice.
    Shi B; Stanfield BB
    Brain Res; 1996 Nov; 740(1-2):89-101. PubMed ID: 8973802
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prolonged axonal survival in transected nerves of C57BL/Ola mice is independent of age.
    Crawford TO; Hsieh ST; Schryer BL; Glass JD
    J Neurocytol; 1995 May; 24(5):333-40. PubMed ID: 7650538
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced oligodendrocyte survival after spinal cord injury in Bax-deficient mice and mice with delayed Wallerian degeneration.
    Dong H; Fazzaro A; Xiang C; Korsmeyer SJ; Jacquin MF; McDonald JW
    J Neurosci; 2003 Sep; 23(25):8682-91. PubMed ID: 14507967
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Effectiveness of the Gene Which Slows the Rate of Wallerian Degeneration in C57BL/Ola Mice Declines With Age.
    Perry VH; Brown MC; Tsao JW
    Eur J Neurosci; 1992; 4(10):1000-2. PubMed ID: 12106435
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Noxa is a critical mediator of p53-dependent motor neuron death after nerve injury in adult mouse.
    Kiryu-Seo S; Hirayama T; Kato R; Kiyama H
    J Neurosci; 2005 Feb; 25(6):1442-7. PubMed ID: 15703398
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Motor axon excitability during Wallerian degeneration.
    Moldovan M; Alvarez S; Krarup C
    Brain; 2009 Feb; 132(Pt 2):511-23. PubMed ID: 19074190
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurotrophic agents prevent motoneuron death following sciatic nerve section in the neonatal mouse.
    Li L; Oppenheim RW; Lei M; Houenou LJ
    J Neurobiol; 1994 Jul; 25(7):759-66. PubMed ID: 8089654
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative and qualitative analysis of Wallerian degeneration using restricted axonal labelling in YFP-H mice.
    Beirowski B; Berek L; Adalbert R; Wagner D; Grumme DS; Addicks K; Ribchester RR; Coleman MP
    J Neurosci Methods; 2004 Mar; 134(1):23-35. PubMed ID: 15102500
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms of motor recovery after subtotal spinal cord injury: insights from the study of mice carrying a mutation (WldS) that delays cellular responses to injury.
    Zhang Z; Guth L; Steward O
    Exp Neurol; 1998 Jan; 149(1):221-9. PubMed ID: 9454631
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A gene affecting Wallerian nerve degeneration maps distally on mouse chromosome 4.
    Lyon MF; Ogunkolade BW; Brown MC; Atherton DJ; Perry VH
    Proc Natl Acad Sci U S A; 1993 Oct; 90(20):9717-20. PubMed ID: 8415768
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Demyelination can proceed independently of axonal degradation during Wallerian degeneration in wlds mice.
    Takada H; Yuasa S; Araki T
    Eur J Neurosci; 2011 Aug; 34(4):531-7. PubMed ID: 21749497
    [TBL] [Abstract][Full Text] [Related]  

  • 32. (-)-Deprenyl alters the survival of adult murine facial motoneurons after axotomy: increases in vulnerable C57BL strain but decreases in motor neuron degeneration mutants.
    Oh C; Murray B; Bhattacharya N; Holland D; Tatton WG
    J Neurosci Res; 1994 May; 38(1):64-74. PubMed ID: 8057392
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Persistence of axonal transport in isolated axons of the mouse.
    Smith RS; Bisby MA
    Eur J Neurosci; 1993 Sep; 5(9):1127-35. PubMed ID: 8281318
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retarded Wallerian degeneration following peripheral nerve transection in C57BL/6/Ola mice is associated with delayed down-regulation of the P0 gene.
    Thomson CE; Mitchell LS; Griffiths IR; Morrison S
    Brain Res; 1991 Jan; 538(1):157-60. PubMed ID: 1708304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. WldS mice are resistant to paclitaxel (taxol) neuropathy.
    Wang MS; Davis AA; Culver DG; Glass JD
    Ann Neurol; 2002 Oct; 52(4):442-7. PubMed ID: 12325073
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Wlds mutation delays robust loss of motor and sensory axons in a genetic model for myelin-related axonopathy.
    Samsam M; Mi W; Wessig C; Zielasek J; Toyka KV; Coleman MP; Martini R
    J Neurosci; 2003 Apr; 23(7):2833-9. PubMed ID: 12684470
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Very Slow Retrograde and Wallerian Degeneration in the CNS of C57BL/Ola Mice.
    Perry VH; Brown MC; Lunn ER
    Eur J Neurosci; 1991; 3(1):102-5. PubMed ID: 12106273
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Calcium-mediated degeneration of the axonal cytoskeleton in the Ola mouse.
    Glass JD; Schryer BL; Griffin JW
    J Neurochem; 1994 Jun; 62(6):2472-5. PubMed ID: 8189250
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Altered brain metabolism in the C57BL/Wld mouse strain detected by magnetic resonance spectroscopy: association with delayed Wallerian degeneration?
    Tsao JW; Paramananthan N; Parkes HG; Dunn JF
    J Neurol Sci; 1999 Sep; 168(1):1-12. PubMed ID: 10500267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term consequences of impaired regeneration on facial motoneurons in the C57BL/Ola mouse.
    Chen S; Bisby MA
    J Comp Neurol; 1993 Sep; 335(4):576-85. PubMed ID: 8227536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.